^○Yu Uneno¹, Matsumoto Shigemi², Sugiyama Osamu², Fukuyama Keita², Muto Manabu¹ (1.Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, 2.Department of Real World Data Research and Development, Graduate School of Medicine, Kyoto University)

^○Phichai Chansriwong¹, Jitprapa Konmun¹, Suwannee Sirilerttrakul², Patamaporn Tangteerakoon⁴, Sineenuch Ckumdee², Buasorn Wetchapan², Sasiphat Khudamkreng², Kedsarin Pinrarot², Aujchayaporn Rattanaphom², Teeraporn Klinumporn², Siraprapa Kritongsuk², Noppakan Wannakansophon³, Yaowarat Chantraporn³, Pinyo Utthiya³, Noppadon Kongsuphon⁴, Pimchanok Tuitemwong^1,5, Nintita Sripaiboonkij Thokanit⁵ (1.Division of Oncology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 2.Department of Nursing, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand., 3.Department of Nursing, Somdech Phra Debaratana Medical Center Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 4.Chemotherapy Pharmacy Service, Compounding Unit, Department of Pharmacy, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand, 5.Ramathibodi Comprehensive Cancer Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University.)

^○Wan-Shiuan Lin¹, Yuan-Hao Yang² (1.Department of Nursing, University of Kang Ning, Taipei, Taiwan, 2.Division of Hematology and Oncology, Department of Medicine, Tao Yuan General Hospital, Taoyuan, Taiwan)

^○Yi-Hsin Yang¹, Chen-Hao Wu¹, Nai-Jung Chiang¹, Yan-Shen Shan², Li-Yuan Bai⁴, Chung-Pin Li⁵, Jen-Shi Chen⁶, Li-Tzong Chen^1,3 (1.National Institute of Cancer Research, National Health Research Institutes, Taiwan, 2.National Cheng Kung University, Taiwan, 3.Kaohsiung Medical University Hospital, Taiwan, 4.China Medical University Hospital, Taiwan, 5.Taipei Veterans General Hospital, Taiwan, 6.Linkou Chang Gung Memorial Hospital, Taiwan)

^○Shosuke Kita^1,2, Noguchi Emi^1,2, Okita Natsuko^1,3, Ushirozawa Nobuko¹, Shibata Taro^1,4, Yonemori Kan^1,2 (1.Office for Advanced Medical Care Evaluation & Health Technology Assessment, National Cancer Center, 2.Department of Medical Oncology, National Cancer Center Hospital, 3.Research Management Division, Clinical Research Support Office, National Cancer Center Hospital, 4.Biostatistics Division, Center for Research Administration and Support, National Cancer Center)

^○Katsutoshi Oda¹, Hidenori Kage¹, Manabu Muto², Tsuchihara Katsuya³, Okita Natsuko⁴, Okuma Yusuki⁵, Kikuchi Junko⁶, Hidekazu Shirota⁷, Hayashi Hideyuki⁸, Toshio Kokuryo⁹, Sakai Daisuke¹⁰, Mariko Kochi¹¹, Makoto Kubo¹², Hirotsugu Kenmotsu¹³, Ushiku Aya^1,14, Masahiko Tanabe^1,15, Tetsuo Ushiku^1,14, Kiyoshi Miyagawa^1,16, Yasuyuki Seto¹⁷ (1.Department of Clinical Genomics, The University of Tokyo Hospital, 2.Department of Therapeutic Oncology, Kyoto University, 3.Division of Translational Informatics, National Cancer Center Hospital East, 4.Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, 5.Department of Thoracic Oncology, National Cancer Center Hospital, 6.Internal Medicine I, Hokkaido University, 7.Department of Clinical Oncology, Tohoku University Hospital, 8.Genomics Unit, Keio Cancer Center, Keio University, 9.Division of Surgical Oncology, Department of Surgery, Nagoya University, 10.Center for Cancer Genomics and Personalized Medicine, Osaka University, 11.Department of Clinical Genetics and Genomic Medicine, Okayama University, 12.Department of Surgery and Oncology, Kyushu University, 13.Division of Thoracic Oncology, Shizuoka Cancer Center, 14.Department of Pathology, The University of Tokyo, 15.Department of Breast and Endocrine Surgery, The University of Tokyo, 16.Center for Disease Biology and Integrative Medicine, The University of Tokyo, 17.Gastrointestinal Surgery, The University of Tokyo)